Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors-Reference-Cited by-同舟云学术

Operable breast cancer: How not to worsen the prognosis, especially in triple negative and stage II tumors

Published:2021-09 Issue: Volume:38 Page:101596
ISSN:0960-7404
Container-title:Surgical Oncology
language:en
Short-container-title:Surgical Oncology

Author:

de Araújo Rogério Agenor,Cordero da Luz Felipe Andrés,da Costa Marinho Eduarda,Mendes Thais Rezende,Nascimento Camila Piqui,Ribeiro Delfino Patrícia Ferreira,Antonioli Rafael Mathias,Ruas Anaisa Carneiro,Alves Andressa Rangel,Araújo Breno Jeha,de Paula Machado João Paulo,Guedes Pereira Thassiana Oliveira,França do Espírito Santo Matheus,Barbosa Silva Marcelo José

Publisher

Elsevier BV

Subject

Oncology,Surgery

Reference39 articles.

1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013;Goldhirsch;Ann. Oncol.,2013

2. Tailoring therapies--improving the management of early breast cancer: St Gallen international expert consensus on the primary therapy of early breast cancer 2015;Coates;Ann. Oncol.,2015

3. Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group;Arriagada;J. Clin. Oncol.,1996

4. Do we need to routinely perform cavity shaving with breast-conserving surgery for breast cancer? A systematic review and meta-analysis;Mohamedahmed;Surg Oncol,2021

5. Disease recurrence and oncological outcome of patients treated surgically with curative intent for estrogen receptor positive, lymph node negative breast cancer;Davey;Surg Oncol,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of the tumor-to-skin distance on axillary lymph node metastasis in breast cancer;Revista da Associação Médica Brasileira;2023

2. Updates and Debate Concerning Margin Adequacy and Management following Breast-Conserving Surgery;Clinical and Experimental Obstetrics & Gynecology;2022-12-09

3. The effect of delayed treatment in breast cancer patients: How much is too late? An experience of a single-center study effect of surgery delay in survival;Surgical Oncology;2022-09

4. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker;ecancermedicalscience;2022-07-20